Loading...
Loading...
India's ketorolac imports from UNITED STATES total $722.1K across 43 shipments from 15 foreign suppliers. EVAUMPHARMA SOLUTIONS INC. leads with $414.1K in import value; the top 5 suppliers together control 95.0% of this origin. Leading Indian buyers include AMNEAL PHARMACEUTICALS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for ketorolac — a diversified sourcing base with multiple active suppliers from UNITED STATES.

EVAUMPHARMA SOLUTIONS INC. is the leading Ketorolac supplier from UNITED STATES to India, with import value of $414.1K across 1 shipments. The top 5 suppliers — EVAUMPHARMA SOLUTIONS INC., EVAUM PHARMA SOLUTIONS INC, AMSTERDAM PHARMA(APTEKA RX INC), CELTIS HEALTHCARE LLC, SPRING BIO SOLUTION — collectively account for 95.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | EVAUMPHARMA SOLUTIONS INC. | $414.1K | 1 | 57.3% |
| 2 | EVAUM PHARMA SOLUTIONS INC | $222.7K | 1 | 30.8% |
| 3 | AMSTERDAM PHARMA(APTEKA RX INC) | $18.6K | 1 | 2.6% |
| 4 | CELTIS HEALTHCARE LLC | $15.9K | 1 | 2.2% |
| 5 | SPRING BIO SOLUTION | $14.8K | 2 | 2.0% |
| 6 | RIOS PHARMACY | $11.0K | 1 | 1.5% |
| 7 | NEWLIFE MEDICALS USA INC | $8.4K | 1 | 1.2% |
| 8 | NEWLIFE MEDICALS (USA). INC. | $7.4K | 2 | 1.0% |
| 9 | RAFF & HALL PHARMACY | $2.6K | 2 | 0.4% |
| 10 | AMSTERDAM PHARMA APTEKA RX INC. | $2.2K | 1 | 0.3% |
| 11 | AMSTERDAM PHARMA (APTEKA RX INC) | $1.2K | 9 | 0.2% |
| 12 | REGIONAL PHARMACY | $1.1K | 6 | 0.1% |
| 13 | SUTPHIN DRUGS INC | $1.0K | 1 | 0.1% |
| 14 | M/S. ENDO USA, INC | $610 | 1 | 0.1% |
| 15 | AGRACE PHARMA | $232 | 3 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $651.6K | 4 | 90.2% |
| 2 | MANKIND PHARMA LIMITED | $28.0K | 3 | 3.9% |
| 3 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED | $15.9K | 1 | 2.2% |
| 4 | SOMERSET THERAPEUTICS LIMITED | $11.0K | 1 | 1.5% |
| 5 | MANKIND PHARMA LTD | $8.4K | 1 | 1.2% |
| 6 | TROIKAA PHARMACEUTICALS LIMITED | $2.6K | 2 | 0.4% |
| 7 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | $1.2K | 9 | 0.2% |
| 8 | MAIVA PHARMA PRIVATE LIMITED | $1.1K | 6 | 0.1% |
| 9 | OPES HEALTH CARE PRIVATE LIMITED | $1.0K | 1 | 0.1% |
| 10 | PAR FORMULATIONS PRIVATE LIMITED | $610 | 1 | 0.1% |
| 11 | HETERO LABS LIMITED | $232 | 3 | 0.0% |
| 12 | AUROBINDO PHARMA LTD | $215 | 1 | 0.0% |
| 13 | MACLEODS PHARMACEUTICALS LTD | $211 | 1 | 0.0% |
| 14 | GRANULES INDIA LIMITED | $120 | 8 | 0.0% |
| 15 | MICRO LABS LIMITED | $2 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Ketorolac suppliers from UNITED STATES to India include EVAUMPHARMA SOLUTIONS INC., EVAUM PHARMA SOLUTIONS INC, AMSTERDAM PHARMA(APTEKA RX INC). The leading supplier is EVAUMPHARMA SOLUTIONS INC. with import value of $414.1K USD across 1 shipments. India imported Ketorolac worth $722.1K USD from UNITED STATES in total across 43 shipments.
India imported Ketorolac worth $722.1K USD from UNITED STATES across 43 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Ketorolac sourced from UNITED STATES include AMNEAL PHARMACEUTICALS PRIVATE LIMITED, MANKIND PHARMA LIMITED, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED. The largest buyer is AMNEAL PHARMACEUTICALS PRIVATE LIMITED with $651.6K in imports across 4 shipments.
The total value of Ketorolac imports from UNITED STATES to India is $722.1K USD, across 43 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
43 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists